AVXL
Anavex Life Sciences Corporation
-22.55%
$11.75 - $9.10
Feb 7th 2023 - Mar 21st 2023
Dec, 5, 2022
I made good profits on Friday and have left profit... See more
Nov, 19, 2022
Also like the fact that the drug intervenes in tau... See more
BNGO
Bionano Genomics Inc
-33.72%
$1.72 - $1.14
Feb 7th 2023 - Mar 21st 2023
Mar, 15, 2023
Under Dr. Holmlin's leadership, OpGen has garn... See more
Mar, 1, 2023
We are just too unique, powerful, useful and cost ... See more
Dec, 5, 2022
I made good profits on Friday and have left profits in stock in support of the research.
Nov, 19, 2022
Also like the fact that the drug intervenes in tau blocking as that is also a target in AD research.
Nov, 7, 2022
Research would show there is a significant chance of awesome results here,
Oct, 26, 2022
Brilliant because the government in Australia recognizes the value of research and grants 43.5% return on each dollar spent.
Mar, 15, 2023
Under Dr. Holmlin's leadership, OpGen has garnered a plethora of accolades and milestones, including the validation of our optical genome mapping technology through extensive clinical research.
Mar, 1, 2023
We are just too unique, powerful, useful and cost effective not to dominate broad and big areas of genetics research and diagnosis.
Jan, 5, 2023
Strong partnerships: Bionano Genomics has established partnerships with leading research institutions and companies, which may help to drive demand for its technology.
Nov, 26, 2022
It accepts various data types that enable clinical research laboratories to process CNVs, SNVs, AOH/LOH (and soon structural variants (SVs) from OGM)—all in a single place.
Nov, 3, 2022
Even with ongoing operating losses, this cash pile should be sufficient to fuel ongoing research and innovation for a long time to come.
Oct, 11, 2022
Praise for OGM from MD Anderson Cancer Center in the United States, one of if not the most prestigious cancer research centers in the U.S. All that and more.
Oct, 7, 2022
But this looks good lets see if it fits the Bill for Cancer Research and Federal Funding Cancer Initiative.